Body and absolute and relative organ weights of rats post PM2.5 exposure (‾χ±s, n =  8). by Cao Wang (1500691)

Subjects:

Modeled concentrations (mg/kg dry weight) of lead (Pb) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of zinc (Zn) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of cadmium (Cd) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

Effect of initial pH and solid–liquid ratio on percentage of fluoride removed; initial pH of 3.5 and 10. by Atsushi Iizuka (3184404)

Subjects:

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of NAC (40 mg/kg/day, i.p.) and ibudilast (7.5 mg/kg/day, i.p.). by María Elena Quintanilla (8068691)

Effectiveness of interventions to decrease hesitancy. by Maximilian Nicolaus Burger (12969212)

Effect of HCQ on T cell activation markers post stimulation with 8μg/mL HPV (human papilloma virus) peptide pool. by Monika M. Kowatsch (11722292)

Subjects:

Effect of HCQ on T cell subsets from <i>ex vivo</i> PBMCs. by Monika M. Kowatsch (11722292)

Subjects:

Effect of HCQ on T cell activation markers post stimulation with 2μg/mL CEF (cytomegalovirus, Epstein Barr virus, and influenza virus) peptide pool. by Monika M. Kowatsch (11722292)

Subjects:

Exposure profiles for 100 agents are arranged in decreasing order then averaged. by Riti Bahl (11292441)

Primary pharmacokinetic parameters of paclitaxel in rats after intravenous administration of Taxol, Abraxane, or self-made nanoparticles at a paclitaxel dose of 7mg/kg (<i>n</i> =... by Yue Gao (263086)

Fig 5 - by Te-Hsing Hsu (16973374)

Flowchart of study selection. by Alejandro Piscoya (782326)

Subjects:

Effect of remdesivir on invasive ventilation at 14 days. by Alejandro Piscoya (782326)

Subjects:

Effect of remdesivir on all-cause mortality at 14 days. by Alejandro Piscoya (782326)

Subjects:

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. by Alejandro Piscoya (782326)

Subjects:

Description of characteristics of included studies. by Alejandro Piscoya (782326)

Subjects:

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

Subjects:

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

Subjects: